Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2007
12/05/2007CN100352493C Method of treating tumors
12/04/2007US7303740 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence
12/04/2007CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007CA2199145C Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
11/2007
11/29/2007WO2007137174A2 Compositions and methods for the detection of vulnerable plaque
11/29/2007WO2007137130A1 Magnetorheological fluids and therapeutic uses thereof
11/29/2007WO2007137121A2 Human oct-2 variant peptide chains, nucleic acids, and methods
11/29/2007WO2007136059A1 Composition for diagnosing amyloid-related disease
11/29/2007WO2007135890A1 Novel compound having affinity for amyloid
11/29/2007WO2007135541A1 11c-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent
11/29/2007WO2007134362A1 2-ARYLPYRAZOLO[L,5-α]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA)
11/29/2007WO2007079953A3 In vitro method to predict the tumor sensitivity to pharmacotherapy and endoradiotherapy
11/29/2007WO2007066115A3 Novel imaging agents for fibrosis
11/29/2007WO2005116226A3 Nanoparticles comprising rna ligands
11/29/2007US20070274911 Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis
11/29/2007US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007US20070274907 Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
11/29/2007DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
11/29/2007CA2653783A1 Novel compound having affinity for amyloid
11/29/2007CA2652440A1 Composition for diagnosis of amyloid-related disease
11/29/2007CA2651763A1 Magnetorheological fluids and therapeutic uses thereof
11/29/2007CA2651677A1 2-arylpyrazolo[l,5-.alpha.]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
11/28/2007EP1859041A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
11/28/2007CN101080240A Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
11/28/2007CN100350981C Radioactive therapeutic Liposomes
11/28/2007CN100350980C Method for preparing 131I marker GM-CSF protein for treating leukemia
11/27/2007US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007US7300644 Targeted combination immunotherapy
11/22/2007WO2007134307A2 Systems, methods and apparatuses for advertisement targeting/distribution
11/22/2007WO2007134236A2 Imaging agents and methods
11/22/2007WO2007133997A2 Elliptical exercise methods and apparatus
11/22/2007WO2007109196A3 Method, system and program for tracking pharmaceutical samples
11/22/2007WO2007076323A3 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
11/22/2007WO2006137886A3 Assay for vitamin b12 absorption and method of making labeled vitamin b12
11/22/2007WO2006128643A3 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine
11/22/2007WO2006115416A3 Liposomes
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070269446 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
11/22/2007US20070269375 Stable Radiopharmaceutical Compositions and Methods for Preparation
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007US20070269370 Compositions and methods for treating B-cell malignancies
11/22/2007US20070269369 Modified Fc molecules
11/21/2007EP1563852B1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils
11/21/2007EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007EP1187919B1 Recombinant adenoviruses encoding the sodium/iodide symporter (nis)
11/21/2007EP0529031B9 Improved inhibitors of thrombin
11/21/2007CN101076357A Enzyme inhibitor imaging agents
11/21/2007CN101074231A [18F] fluoraro-marked purine compound, its production and use
11/20/2007US7297820 Thio substituted stilbene amines; inhibiting the aggregation of amyloid proteins
11/20/2007US7297325 Hydrophilic light absorbing compositions for determination of physiological function
11/20/2007CA2287838C Radionuclide associated with nucleotide polyphosphate as tumor imaging agents
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/15/2007WO2007130964A2 Radioactive material sequestration
11/15/2007WO2007130365A2 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
11/15/2007WO2007128557A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody
11/15/2007WO2007084693A3 Immunoconjugates with improved efficacy for the treatment of diseases
11/15/2007WO2007041397A3 Targeted pharmaceuticals and ligands
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264191 Materials and Methods Relating to the Treatment of Glioblastomas
11/15/2007DE102006021495A1 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit Use of perfluoroalkyl-containing metal complexes as contrast agents for the diagnosis of Alzheimer's disease
11/15/2007CA2650953A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody
11/15/2007CA2650904A1 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
11/14/2007EP1854781A1 Radioactive halogen-labeled phenyloxyaniline derivatives
11/14/2007EP1853572A1 Fluorinated phno and analogs thereof
11/14/2007EP1853324A1 Caspase-3 substrate comprising imaging agents
11/14/2007EP1483262B1 Coumarines useful as biomarkers
11/14/2007CN101072591A Pet and magnetic resonance for screening alzheimer's diseasetherapeutics
11/13/2007US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
11/13/2007US7294486 Using streptomyces fluorinase to generate 5'-fluoro-5'-deoxyadenosine or fluoroacetate for use as tumor imaging agent
11/13/2007US7294329 Poly(vinyl acetal) coatings for implantable medical devices
11/08/2007WO2007127160A2 Agrm2 antigen
11/08/2007WO2007126896A2 A magnetic resonance imaging method using vanadyl-based contrast agents
11/08/2007WO2007126733A2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/08/2007WO2007125988A1 Novel compound having affinity to amyloid
11/08/2007WO2007088129A3 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging
11/08/2007WO2007066089A3 Radiolabelling method using polymers
11/08/2007WO2007062343A3 Mitochondria-targeted antioxidant prodrugs and methods of use
11/08/2007US20070259811 Method of modulating the proliferation of medullary thyroid carcinoma cells
11/08/2007US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007US20070258893 Compositions and methods for imaging expression of cell surface receptors
11/08/2007US20070258892 Composition, Comprising L-Serine, L-Isoleucine, Folic Acid and Trace Elements, for Treating Psoriasis
11/08/2007US20070258891 Conjugates of N-Hydroxypropymethacrylamide-Methacrylate Copolymer with Nuclide Activation Agent and/or Anti-Cancer Compounds
11/08/2007US20070258890 Anthracycline Derivatives
11/08/2007US20070258889 Novel nanoparticles and use thereof
11/08/2007US20070258888 Contrast Agent for Medical Imaging Techniques and Usage Thereof
11/08/2007US20070258887 antemortem method of diagnosing Alzheimer's disease and quantitating extent or progression of amyloid deposits by in vivo imaging of brain
11/08/2007US20070258886 Methods for assessing cell labeling
11/08/2007US20070258885 Device for concentrating Technetium-99m pertechnetate and method thereof
11/08/2007CA2657312A1 Novel compound having affinity to amyloid
11/08/2007CA2651800A1 Agrm2 antigen
11/08/2007CA2644530A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/07/2007EP1850881A2 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr epxression in malignant tumors
11/07/2007EP1850856A1 Dosage and method for attaining beneficial levels of vitamin d3
11/07/2007EP1395600B1 Products containing charged biomaterials and method for the preparation thereof
11/07/2007EP0746340B1 Peptide-chelator conjugates
11/07/2007CN101068577A Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy
11/07/2007CN101068576A Imaging infection with compounds that bind to thymidine kinase
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 243